BANK OF AMERICA CORP /DE/ - EFFECTOR THERAPEUTICS INC ownership

EFFECTOR THERAPEUTICS INC's ticker is and the CUSIP is 28202V108. A total of 32 filers reported holding EFFECTOR THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
BANK OF AMERICA CORP /DE/ ownership history of EFFECTOR THERAPEUTICS INC
ValueSharesWeighting
Q2 2023$83
+137.1%
1000.0%0.00%
Q1 2023$35
+75.0%
100
+108.3%
0.00%
Q4 2022$20480.00%
Other shareholders
EFFECTOR THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
SR ONE CAPITAL MANAGEMENT, LP 6,822,114$9,687,0004.74%
Abingworth LLP 4,822,114$6,462,0002.07%
OUP Management Co., LLC 1,025,697$1,456,0002.00%
Column Group LLC 4,309,329$6,119,0001.30%
Evolution Capital Management LLC 527,885$750,0001.12%
SECTORAL ASSET MANAGEMENT INC 2,382,644$3,383,0000.68%
Parallel Advisors, LLC 1,693,559$2,405,0000.11%
RESOLUTE FINANCIAL, LLC 30,000$43,0000.04%
Oasis Management Co Ltd. 100,000$142,0000.02%
Blackstone Inc. 1,308,587$1,858,0000.01%
View complete list of EFFECTOR THERAPEUTICS INC shareholders